Schedule 13D ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2022-07-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-22-000489
- Form type
- SC 13D
- Filer
- Growth Equity Opportunities 18 VGE, LLC
- CIK
- CIK 1917895
- Filed
- Jul 19, 2022
- Reporting period
- Jul 06, 2022
- Description
- Schedule 13D beneficial ownership